The US pharmaceutical contract manufacturing market is poised for significant expansion, driven by a compound annual growth rate (CAGR) of 4.56%. By 2035, the market is projected to reach an impressive size of USD 86.16 billion, up from USD 52.74 billion in 2024. This trend reflects a robust shift toward outsourcing, where pharmaceutical companies increasingly rely on specialized manufacturers...